61% of patients in the radial ESWT group compared to 42% in the placebo group achieved >60% improvement from baseline at 12 weeks using the VAS rating scale”
- GURGESMYER ET AL 2007 N=251

182 of 202 practitioners
when asked “Would you choose
to use the Swiss Dolorclast again?” answered YES, only 3 answered no.